Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.
Our common stock is traded on the Global Select Market tier of the NASDAQ Stock Market LLC, under the symbol “ANGO.”
The following table sets forth, for the fiscal quarters indicated, the high and low sale prices for our common stock as reported by the NASDAQ Stock Market.
Sale Price
High Low
Year ended May 31, 2024
Fourth Quarter $ 7.03 $ 5.27
Third Quarter $ 8.04 $ 5.49
Second Quarter $ 7.73 $ 6.17
First Quarter $ 11.16 $ 8.00
Sale Price
High Low
Year ended May 31, 2023
Fourth Quarter $ 12.65 $ 8.29
Third Quarter $ 15.48 $ 12.06
Second Quarter $ 22.81 $ 12.51
First Quarter $ 24.30 $ 17.83
As of July 24, 2024, there were 166 holders of record of our common stock.
Dividends
We did not declare any cash dividends on our common stock during our last three fiscal years. We do not anticipate paying any cash dividends on our common stock for the foreseeable future.
Performance Graph
The graph below matches AngioDynamics, Inc.’s cumulative 5-year total shareholder return on common stock with the cumulative total returns of the NASDAQ Composite index, the RDG SmallCap Medical Devices index, and the S&P 500 Health Care index. The graph tracks the performance of a $100 investment in our common stock and in each index (with the reinvestment of all dividends) from May 31, 2019 to May 31, 2024. The stock price performance included in this graph is not necessarily indicative of future stock price performance.
31
Item 6. [Reserved]
32
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.